SPRB - Spruce Biosciences  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

SPRB is currently covered by 4 analysts with an average price target of $233.04. This is a potential upside of $153.18 (191.81%) from yesterday's end of day stock price of $79.86.

Spruce Biosciences 's activity chart (see below) currently has 28 price targets and 53 ratings on display. The stock rating distribution of SPRB is 50% HOLD and 50% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 20.24% with an average time for these price targets to be met of 62 days.

Highest price target for SPRB is $259, Lowest price target is $160, average price target is $213.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 22-Dec-2025. First documented stock forecast 03-Nov-2020.

Currently out of the existing stock ratings of SPRB, 3 are a HOLD (50%), 3 are a BUY (50%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 22-Dec-2025

$220

$138.48 (169.87%)

1 months 8 days ago
(22-Dec-2025)

0/5 (0%)

$141.26 (179.40%)

Hold Since 14-Mar-2024

$160

$78.48 (96.27%)

$160

1 months 27 days ago
(03-Dec-2025)

3/6 (50%)

$70.8 (79.37%)

162

Buy Since 28-Oct-2025

$259

$177.48 (217.71%)

$254

2 months 19 days ago
(11-Nov-2025)

0/3 (0%)

$146.34 (129.90%)

Hold Since 13-Mar-2024

9 months 14 days ago
(16-Apr-2025)

2/7 (28.57%)

$-239.25 (-61.46%)

13

Hold Since 11-Dec-2024

1 years 1 months 19 days ago
(11-Dec-2024)

0/1 (0%)

$416.25 (226.53%)

Show more analysts

Please expand the browser size to see the chart

What is SPRB (Spruce Biosciences ) average time for price targets to be met?

On average it took 62 days on average for the stock forecasts to be realized with a an average price target met ratio 20.24

Which analyst has the current highest performing score on SPRB (Spruce Biosciences ) with a proven track record?

TIAGO FAUTH

Which analyst has the current lower performing score on SPRB (Spruce Biosciences ) with a proven track record?

JONATHAN WOLLEBEN

Which analyst has the most public recommendations on SPRB (Spruce Biosciences )?

Tiago Fauth works at WELLS FARGO and has 8 price targets and 5 ratings on SPRB

Which analyst is the currently most bullish on SPRB (Spruce Biosciences )?

Martin Auster with highest potential upside - $368.48

Which analyst is the currently most reserved on SPRB (Spruce Biosciences )?

Gregory Renza with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?